Aeterna Zentaris Now Covered by StockNews.com
| AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Slightly above 62% of AEZS Old's investor base is looking to short. The analysis of current outlook of investing in AEZS Old suggests that many traders are alarmed regarding AEZS Old's prospects. AEZS Old's investing sentiment can be driven by a variety of factors including economic data, AEZS Old's earnings reports, geopolitical events, and overall market trends.
AEZS |
Equities researchers at StockNews.com started coverage on shares of Aeterna Zentaris in a research report issued to clients and investors on Monday. The brokerage set a sell rating on the biopharmaceutical companys stock. Separately, HC Wainwright decreased their price objective on shares of Aeterna Zentaris from 28.00 to 15.00
Read at thelincolnianonline.com
 |
AEZS Old Fundamental Analysis
We analyze AEZS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AEZS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AEZS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
AEZS Old is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
AEZS Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AEZS Old stock to make a market-neutral strategy. Peer analysis of AEZS Old could also be used in its relative valuation, which is a method of valuing AEZS Old by comparing valuation metrics with similar companies.
Peers
AEZS Old Related Equities
| RNAZ | Transcode Therapeutics | 24.64 | ||||
| PULM | Pulmatrix | 12.77 | ||||
| ATXI | Avenue Therapeutics | 6.36 | ||||
| BPTH | Bio Path | 3.57 | ||||
| TNXP | Tonix Pharmaceuticals | 1.84 | ||||
| IBIO | Ibio | 0.98 | ||||
| MBRX | Moleculin Biotech | 0.57 | ||||
| ADIL | Adial Pharmaceuticals | 0 | ||||
| RVPH | Reviva Pharmaceuticals | 0.52 | ||||
| JAGX | Jaguar Animal | 1.33 | ||||
| ADTX | Aditxt | 8.33 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in AEZS Stock
If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |